Echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction

被引:0
|
作者
Shemirani, Hasan [2 ]
Hemmati, Rohola [3 ]
Khosravi, Alireza
Gharipour, Mojgan [1 ]
Jozan, Mahnaz [2 ]
机构
[1] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Cardiac Rehabil Res Ctr, Isfahan Cardiovasc Res Ctr,Cardiovasc Res Inst, Esfahan, Iran
[2] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Hypertens Res Ctr, Esfahan, Iran
[3] Ilam Univ Med Sci, Sch Med, Ilam, Iran
来源
JOURNAL OF RESEARCH IN MEDICAL SCIENCES | 2012年 / 17卷 / 02期
关键词
Echocardiographic; left ventricular mass; left ventricular hypertrophy; Diastolic dysfunction; SOCIETY-OF-CARDIOLOGY; HEART-FAILURE; PROGNOSIS; HYPERTENSION; DIAGNOSIS; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: early diagnosis of left ventricular mass (LVM) inappropriateness and left ventricular hypertrophy (LVH) can result in preventing diastolic left ventricular dysfunction and its related morbidity and mortality. This study was performed to determine if diastolic dysfunction is associated with LVH and inappropriate LVM. Materials and Methods: one hundred and twenty five uncomplicated hypertension from Isfahan Healthy Heart Program underwent two-dimensional echocardiography. Inappropriate LVM was defined as an LVM index greater than 88 g/m2 of body-surface area in women and greater than 102 g/m2 in men. LVH-defined septal and posterior wall thickness greater than 0/9 cm in women and greater than 1 cm in men, respectively. Echocardiographic parameters, including early diastolic peak velocity (E)/late diastolic peak velocity (A), deceleration time (DT), and E/early mitral annulus velocity (E') were measured. Results: the mean systolic and diastolic blood pressure at the patients' admission day were 142.87 +/- 18.12 and 88.45 +/- 9.18 mmHg, respectively. Totally, 21.7% of subjects had inappropriate LV mass that moderate and severe abnormal LV mass was revealed in 5.6% and 5.6%, respectively. The mean of age and BMI was significantly higher in patients with moderate left ventricular hypertrophy (P < 0.05). Adjusted by age, gender, BMI, and systolic and diastolic blood pressures, both E/A ratio and deceleration time were higher in those with the severer ventricular hypertrophy. Subjects with severe showed significantly higher BMI 33.7 +/- 3.7 (P < 0.001). There was a slight difference between the grade of diastolic dysfunction and the severity of inappropriate LV mass (P = 0.065). But no significant difference was found between E/A, E/E', and deceleration time and the level of inappropriate LV mass (P > 0.05). Spearman's Rank test was used to test the correlation between diastolic dysfunction and LV mass (P = 0.025). Conclusion: LVH is correlated with the severity of diastolic dysfunction manifested by the E/A value and deceleration time, but inappropriate LVM can slightly predict diastolic dysfunction severity in uncomplicated hypertension.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 50 条
  • [21] Relationship of Electrocardiographic Left Ventricular Hypertrophy to the Presence of Diastolic Dysfunction
    Krepp, Joseph M.
    Lin, Fay
    Min, James K.
    Devereux, Richard B.
    Okin, Peter M.
    ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2014, 19 (06) : 552 - 560
  • [22] Pathophysiology and Echocardiographic Diagnosis of Left Ventricular Diastolic Dysfunction
    Silbiger, Jeffrey J.
    JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2019, 32 (02) : 216 - +
  • [23] Left Ventricular Diastolic Dysfunction in ARDS Patients
    Formenti, Paolo
    Coppola, Silvia
    Massironi, Laura
    Annibali, Giacomo
    Mazza, Francesco
    Gilardi, Lisa
    Pozzi, Tommaso
    Chiumello, Davide
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
  • [24] Treatment of diastolic dysfunction in hypertensive patients without left ventricular hypertrophy
    E Molinero
    N Murga
    JD Sagastagoitia
    R Fernández
    J Garrido
    Journal of Human Hypertension, 1998, 12 : 21 - 27
  • [25] Left Ventricular Hypertrophy Determines the Severity of Diastolic Dysfunction in Patients with Nonvalvular Atrial Fibrillation and Preserved Left Ventricular Systolic Function
    Moon, Jeonggeun
    Rim, Se-Joong
    Cho, In Jeong
    Lee, Sang-Hak
    Choi, Seonghoon
    Chung, Wook-Jin
    Byun, Young-Sup
    Ryu, Sung-Kee
    Pyun, Wook-Bum
    Kim, Jong-Youn
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, 32 (08) : 540 - 546
  • [26] Role of left ventricular hypertrophy in diastolic dysfunction in aged hypertensive patients
    Zabalgoitia, N
    Rahman, SNU
    Haley, WE
    Abochamh, DA
    Oneschuk, L
    Amerena, J
    Yarows, S
    Krause, L
    Yunis, C
    Lucas, C
    JOURNAL OF HYPERTENSION, 1997, 15 (10) : 1175 - 1179
  • [27] Treatment of diastolic dysfunction in hypertensive patients without left ventricular hypertrophy
    Molinero, E
    Murga, N
    Sagastagoitia, JD
    Fernandez, R
    Garrido, J
    JOURNAL OF HUMAN HYPERTENSION, 1998, 12 (01) : 21 - 27
  • [28] Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)
    Wachtell, Kristian
    Palmieri, Vittorio
    Gerdts, Eva
    Bella, Jonathan N.
    Aurigemma, Gerard P.
    Papademetriou, Vasilios
    Dahlof, Bjorn
    Aalto, Tapio
    Ibsen, Hans
    Rokkedal, Jens E.
    Devereux, Richard B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (07) : 999 - 1005
  • [29] Low-Grade Albuminuria Is Associated with Left Ventricular Hypertrophy and Diastolic Dysfunction in Patients with Hypertension
    Wang, Tingjun
    Zhong, Hongbin
    Lian, Guili
    Cai, Xiaoqi
    Gong, Jin
    Ye, Chaoyi
    Xie, Liangdi
    KIDNEY & BLOOD PRESSURE RESEARCH, 2019, 44 (04) : 590 - 603
  • [30] Echocardiographic markers of cardiac amyloidosis in patients with heart failure and left ventricular hypertrophy
    Polo, Jorge Melero
    Barrenechea, Ana Roteta Unceta
    Marti, Pablo Revilla
    Gutierrez, Anyuli Gracia
    Juana, Esperanza Bueno
    Ayala, Saida Atienza
    Arregui, Miguel Angel Aibar
    CARDIOLOGY JOURNAL, 2023, 30 (02) : 266 - 275